Private Equity’s Grip on India’s Healthcare: A Critical Look

Ameer Shahul’s book, “The Silent Syndicate: How Big Finance is Destroying India’s Healthcare,” offers a critical examination of global financial interests’ profound impact on India’s healthcare system. The author argues that while this ownership shift brings some benefits, these are not equitably distributed, moving away from India’s foundational principle of healthcare as a right.

Unpacking the ‘Syndicate’s’ Operations

Shahul’s investigation leverages financial data, personal narratives, and on-the-ground reporting to reveal the operational methods of this “syndicate.” He highlights specific transformations within the sector.

• Institutions like Kimshealth in Thiruvananthapuram, once driven by altruism, were acquired by corporate entities such as Blackstone.
• These acquisitions subsequently shifted their focus to profit-driven models.

Liberalization’s Enduring Legacy

The origins of these acquisitions trace back to India’s economic liberalization in the 1990s. Structural adjustment programs, encouraged by international bodies like the World Bank and IMF, opened the healthcare sector to private capital.

This era saw a dramatic increase in private enterprise due to insufficient public health spending, fostering a wave of corporatized hospitals and diagnostic centers.

The Profit Motive in Healthcare

Shahul presents a counter-narrative, asserting that foreign capital primarily views India’s expanding healthcare market as a source of profit. This perspective is driven by the “predictability of illness and thus the certainty of cash flow,” with little regard for public health priorities or human rights.

Private equity firms have acquired major hospital networks and diagnostic giants across the country.

• Major hospital networks include Apollo, Fortis, Max, Manipal, and Medanta.
• Diagnostic giants acquired include SRL and Dr Lal PathLabs.

Regulatory Gaps and Operational Shifts

The author contrasts India’s lenient regulatory environment with more stringent global frameworks, such as the UK’s NHS or Germany’s diagnosis-related group systems. He concludes that India’s system is an “open field for prioritising profit.”

A doctor cited in the book observed that corporate chains often prioritize bed occupancy over patient well-being, with key decisions frequently made in foreign boardrooms.

Systemic Challenges and Proposed Solutions

The book meticulously maps the intricate web of global capital flows across various healthcare segments, including hospitals, diagnostics, medical devices, patient data, pharmaceuticals, and health insurance, often noting the opacity of these operations.

Shahul also addresses systemic issues within Indian healthcare, such as the influence of powerful lobbies on national policy and aggressive patents limiting access to life-saving drugs. He points out the paradox of India being the world’s largest producer of generic medicines while its domestic system drives millions into debt due to profit-focused care.

Finally, the book proposes actionable solutions, advocating for foreign investment to align with national health goals. It also suggests establishing independent commissions to assess the benefits of these investments and appointing relevant professionals.